MX2016013911A - Sales y polimorfos de un compuesto imidazopiridinil-aminopiridina sustituido. - Google Patents
Sales y polimorfos de un compuesto imidazopiridinil-aminopiridina sustituido.Info
- Publication number
- MX2016013911A MX2016013911A MX2016013911A MX2016013911A MX2016013911A MX 2016013911 A MX2016013911 A MX 2016013911A MX 2016013911 A MX2016013911 A MX 2016013911A MX 2016013911 A MX2016013911 A MX 2016013911A MX 2016013911 A MX2016013911 A MX 2016013911A
- Authority
- MX
- Mexico
- Prior art keywords
- compound
- salts
- polymorphs
- free base
- forms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/04—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing only one sulfo group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
Abstract
La presente solicitud se refiere a sales del compuesto A, 3-(3-(4-(1-aminociclobutil)fenil)-5-fenil-3H-imidazo[4,5-b] piridin-2-il)piridin-2-amina, formas sólidas de la base libre del compuesto A o de las sales del compuesto A, formas amorfas de la base libre del compuesto A o de sales del compuesto A, formas cristalinas de la base libre del compuesto A o de sales del compuesto A, polimorfos de la base libre del compuesto A o de sales del compuesto A y mesomorfos de la base libre de compuesto A o de sales del compuesto A; la presente solicitud también se refiere a composiciones farmacéuticas que comprenden estas sales, formas de estado sólido, formas amorfas, formas cristalinas, polimorfos o mesomorfos de la base libre del compuesto A o de sales del compuesto A; la presente solicitud proporciona métodos para preparar estas sales, formas sólidas, formas amorfas, formas cristalinas, polimorfos o mesomorfos de la base libre del compuesto A o de las sales del compuesto A.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201461982692P | 2014-04-22 | 2014-04-22 | |
PCT/US2015/027045 WO2015164479A1 (en) | 2014-04-22 | 2015-04-22 | Salts and polymorphs of a substituted imidazopyridinyl-aminopyridine compound |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2016013911A true MX2016013911A (es) | 2017-03-07 |
Family
ID=54321420
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2016013911A MX2016013911A (es) | 2014-04-22 | 2015-04-22 | Sales y polimorfos de un compuesto imidazopiridinil-aminopiridina sustituido. |
MX2020009412A MX2020009412A (es) | 2014-04-22 | 2016-10-21 | Sales y polimorfos de un compuesto imidazopiridinil-aminopiridina sustituido. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2020009412A MX2020009412A (es) | 2014-04-22 | 2016-10-21 | Sales y polimorfos de un compuesto imidazopiridinil-aminopiridina sustituido. |
Country Status (20)
Country | Link |
---|---|
US (1) | US9422283B2 (es) |
EP (2) | EP3653627A1 (es) |
JP (2) | JP6961348B2 (es) |
KR (1) | KR20160143842A (es) |
CN (2) | CN106795153B (es) |
AU (2) | AU2015249809B2 (es) |
BR (1) | BR112016024521A2 (es) |
CA (1) | CA2945778A1 (es) |
DK (1) | DK3134407T3 (es) |
ES (1) | ES2745156T3 (es) |
HU (1) | HUE046150T2 (es) |
IL (1) | IL248342A (es) |
MX (2) | MX2016013911A (es) |
PL (1) | PL3134407T3 (es) |
PT (1) | PT3134407T (es) |
RU (1) | RU2732125C2 (es) |
SG (1) | SG11201608722QA (es) |
TW (1) | TWI652266B (es) |
WO (1) | WO2015164479A1 (es) |
ZA (1) | ZA201607107B (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2022542822A (ja) * | 2019-07-17 | 2022-10-07 | サミット (オックスフォード) リミティド | リジニラゾールの調製方法およびその結晶形態 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
US6403588B1 (en) * | 2000-04-27 | 2002-06-11 | Yamanouchi Pharmaceutical Co., Ltd. | Imidazopyridine derivatives |
WO2001083481A1 (fr) * | 2000-04-27 | 2001-11-08 | Yamanouchi Pharmaceutical Co., Ltd. | Derives d'imidazopyridine |
GB0206860D0 (en) * | 2002-03-22 | 2002-05-01 | Glaxo Group Ltd | Compounds |
EP2251341A1 (en) * | 2005-07-14 | 2010-11-17 | Astellas Pharma Inc. | Heterocyclic Janus kinase 3 inhibitors |
ATE453635T1 (de) * | 2006-03-22 | 2010-01-15 | Vertex Pharma | C-met-proteinkinasehemmer zur behandlung proliferativer erkrankungen |
US8136543B2 (en) * | 2009-01-27 | 2012-03-20 | Fisher Controls International, Llc | Axial flow control valves having an internal actuator |
IT1395963B1 (it) * | 2009-06-04 | 2012-11-02 | Rottapharm Spa | Forme cristalline di 6-(1h-imidazol-1-il)-2-fenil chinazolina e dei suoi sali |
EP2519522B1 (en) * | 2009-12-30 | 2014-09-24 | ArQule, Inc. | Substituted imidazopyridinyl-aminopyridine compounds |
WO2012177844A2 (en) | 2011-06-24 | 2012-12-27 | Arqule, Inc. | Substituted imidazopyridinyl-aminopyridine compounds |
US8815854B2 (en) | 2011-06-24 | 2014-08-26 | Arqule, Inc. | Substituted imidazopyridinyl compounds |
-
2015
- 2015-04-22 DK DK15783385.6T patent/DK3134407T3/da active
- 2015-04-22 CN CN201580033637.3A patent/CN106795153B/zh not_active Expired - Fee Related
- 2015-04-22 ES ES15783385T patent/ES2745156T3/es active Active
- 2015-04-22 JP JP2016564070A patent/JP6961348B2/ja active Active
- 2015-04-22 KR KR1020167032091A patent/KR20160143842A/ko not_active Application Discontinuation
- 2015-04-22 CA CA2945778A patent/CA2945778A1/en active Pending
- 2015-04-22 HU HUE15783385A patent/HUE046150T2/hu unknown
- 2015-04-22 SG SG11201608722QA patent/SG11201608722QA/en unknown
- 2015-04-22 AU AU2015249809A patent/AU2015249809B2/en not_active Ceased
- 2015-04-22 WO PCT/US2015/027045 patent/WO2015164479A1/en active Application Filing
- 2015-04-22 EP EP19184995.9A patent/EP3653627A1/en not_active Withdrawn
- 2015-04-22 PL PL15783385T patent/PL3134407T3/pl unknown
- 2015-04-22 CN CN202010103721.0A patent/CN111499627A/zh active Pending
- 2015-04-22 PT PT15783385T patent/PT3134407T/pt unknown
- 2015-04-22 EP EP15783385.6A patent/EP3134407B1/en active Active
- 2015-04-22 BR BR112016024521A patent/BR112016024521A2/pt not_active Application Discontinuation
- 2015-04-22 US US14/693,015 patent/US9422283B2/en active Active
- 2015-04-22 MX MX2016013911A patent/MX2016013911A/es active IP Right Grant
- 2015-04-22 RU RU2016145264A patent/RU2732125C2/ru active
- 2015-04-22 TW TW104112870A patent/TWI652266B/zh not_active IP Right Cessation
-
2016
- 2016-10-13 IL IL248342A patent/IL248342A/en active IP Right Grant
- 2016-10-14 ZA ZA2016/07107A patent/ZA201607107B/en unknown
- 2016-10-21 MX MX2020009412A patent/MX2020009412A/es unknown
-
2019
- 2019-07-19 AU AU2019206118A patent/AU2019206118B2/en not_active Ceased
- 2019-12-24 JP JP2019232895A patent/JP2020073523A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12016501972A1 (en) | Bicyclic-fused heteroaryl or aryl compounds and their use as irak4 inhibitors | |
PH12017500408B1 (en) | Heteroaryl compounds as btk inhibitors and uses thereof | |
SG10201805628TA (en) | Deuterated heterocyclic compounds and their use as imaging agents | |
WO2014144545A3 (en) | Substituted benzoxazoles and methods of use thereof | |
MX2016011992A (es) | Derivados de piperidina-diona. | |
GEP201706774B (en) | Heterocyclyl compounds | |
PH12018501643A1 (en) | Tlr7 agonist crystalline form a, preparation method and use thereof | |
PH12018501644A1 (en) | Tlr7 agonist maleate salt, crystalline forms c, d and e thereof, preparation methods and uses of maleate salt and crystalline forms | |
WO2015142903A3 (en) | Method of controlling lactate production with piperdine-dione derivatives | |
WO2016071435A3 (en) | Synthesis of copanlisib and its dihydrochloride salt | |
MY183123A (en) | Synthesis of copanlisib and its di hydrochloride salt | |
MX2018009503A (es) | Sal de trifluoroacetato de agonista de tlr7 y forma cristalina b de la misma, metodos de preparacion y usos. | |
MX2020002123A (es) | Sales de ribociclib y formas en estado sólido de las mismas. | |
MX2019012454A (es) | Compuesto solido cristalino novedoso de clorhidrato de 3-fenil-4-propil-1-(piridin-2-il)-1h-pirazol-5-ol. | |
MX2016004963A (es) | Sal y formas cristalinas de inhibidores de quinasa tipo polo-4. | |
MX2016009621A (es) | Derivados de fur0-3-carboxamida y metodos de uso. | |
IL253239A0 (en) | Method for preparing 3-(3-(4-(1-aminocyclobutyl)phenyl)-5-phenyl-3h-imidazo[5,4[b-pyridin-2-yl)pyridin-2-amine | |
IN2013DE02503A (es) | ||
WO2014049586A3 (en) | Process for the preparation of dabigatran etexilate or pharmaceutically acceptable salt thereof | |
MX2020009412A (es) | Sales y polimorfos de un compuesto imidazopiridinil-aminopiridina sustituido. | |
WO2014195977A3 (en) | Novel polymorphs of vismodegib | |
WO2015102024A3 (en) | Novel substituted 5 membered heterocyclic compounds and preparation thereof | |
EP3398946A4 (en) | SALT OF MORPHOLINE DERIVATIVE AND ITS CRYSTALLINE FORM, AND PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF | |
IN2013MU03508A (es) | ||
PH12015502703A1 (en) | Pharmaceutical compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |